Moy Andrea Primiani, Maryamchik Elena, Nikolskaia Olga V, Nazarian Rosalynn M
Pathology Service, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
J Cutan Pathol. 2017 Jun;44(6):548-552. doi: 10.1111/cup.12947.
Morphea (localized scleroderma) and eosinophilic fasciitis (EF) are rare fibrosing disorders which may present a diagnostic challenge. While histopathologic features are often distinct, in some cases there may be overlap. T-cells contribute to etiopathogenesis of both autoimmune conditions. We sought to determine whether T-cell immune polarization enables histopathologic distinction.
MATERIALS & METHODS: We retrospectively examined clinicopathologically confirmed cases of morphea (n = 12) and EF (n = 8) using immunohistochemistry for CD3, CD8, and dual staining for CD4 with T-bet, GATA-3, STAT-3 or BNC-2 (transcription factors reported to be specific and mutually exclusive for Th1, Th2, Th17 and Th22 cells, respectively) to characterize the T-cell infiltrate.
No significant difference in CD3+ cells was identified (P = .195), however, the CD4/CD8+ T-cell ratio was significantly greater in morphea compared to EF (1.2 and 0.6, respectively; P = .034). Th1/Th2 was significantly lower in morphea compared to EF (1.7 and 2.7, respectively; P = .027). The percent of Th17+ cells was significantly higher in EF (P = 0.041). No significant difference in percent of Th22+ cells was identified.
Morphea and EF may be histopathologically distinguished based on helper T-cell subtype polarization. These findings offer novel insight into our understanding of disease pathogenesis and support a role for Th1/Th2 immune regulation and Th17 inhibition in anti-fibrotic therapeutic strategy.
硬斑病(局限性硬皮病)和嗜酸性筋膜炎(EF)是罕见的纤维化疾病,可能带来诊断挑战。虽然组织病理学特征通常不同,但在某些情况下可能存在重叠。T细胞参与这两种自身免疫性疾病的发病机制。我们试图确定T细胞免疫极化是否有助于组织病理学鉴别。
我们回顾性检查了经临床病理确诊的硬斑病病例(n = 12)和EF病例(n = 8),采用免疫组织化学检测CD3、CD8,并对CD4与T-bet、GATA-3、STAT-3或BNC-2(分别报道为Th1、Th2、Th17和Th22细胞特异性且相互排斥的转录因子)进行双重染色,以表征T细胞浸润情况。
未发现CD3+细胞有显著差异(P = 0.195),然而,硬斑病中的CD4/CD8+ T细胞比值显著高于EF(分别为1.2和0.6;P = 0.034)。硬斑病中的Th1/Th2显著低于EF(分别为1.7和2.7;P = 0.027)。EF中Th17+细胞的百分比显著更高(P = 0.041)。未发现Th22+细胞百分比有显著差异。
硬斑病和EF可根据辅助性T细胞亚群极化在组织病理学上进行鉴别。这些发现为我们理解疾病发病机制提供了新的见解,并支持Th1/Th2免疫调节和Th17抑制在抗纤维化治疗策略中的作用。